Ilginatinib hydrochloride
Ilginatinib hydrochloride is a potent, orally bioavailable JAK2 inhibitor used in research. It has demonstrated activity in cellular assays and animal models relevant to myeloproliferative neoplasms and hematological malignancies.
Product Specifications
CAS Number
1239358-85-0
Product Name Alternative
Bioavailable, Ilginatinib, Ilginatinib hydrochloride, Ilginatinib Hydrochloride, Janus kinase, JAK, JAK2, JAK1, JAK3, inhibit, NS018, NS-018, NS018 Hydrochloride, NS-018 Hydrochloride, NS-018 hydrochloride, NS 018, NS 018 Hydrochloride, orally, Inhibitor, Tyrosine Kinases, Tyk2, TyrosineKinases
Field of Research
Cardiovascular Research, Epigenetics & Chromatin, Signal Transduction, Stem Cell & Developmental Biology
Purity
95.30% (May vary between batches)
Solubility
DMSO:60 mg/mL (140.88 mM) ;10% DMSO+90% Saline:2.5 mg/mL (5.87 mM) ; H2O:2 mg/mL (4.7 mM)
Smiles
Cl.C[C@H] (Nc1cc (cc (Nc2cnccn2) n1) -c1cnn (C) c1) c1ccc (F) cc1
Molecular Formula
C21H21ClFN7
Molecular Weight
425.89
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog